John C P Kingdom
Overview
Explore the profile of John C P Kingdom including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
969
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hobson S, Kingdom J, Windrim R, Murji A, Milligan N, Pacheco J, et al.
Int J Gynaecol Obstet
. 2021 Apr;
157(1):130-139.
PMID: 33890292
Objective: To describe the evolution and evaluation of protocol-based multidisciplinary quality improvement (QI) in women undergoing cesarean hysterectomy for radiologically suspected and pathologically confirmed placenta accreta spectrum (PAS) disorders. Methods:...
2.
Dunk C, Kwan M, Hazan A, Walker S, Wright J, Harris L, et al.
Front Endocrinol (Lausanne)
. 2019 Apr;
10:160.
PMID: 30949130
Failure of uterine vascular transformation is associated with pregnancy complications including Intra Uterine Growth Restriction (IUGR). The decidua and its immune cell populations play a key role in the earliest...
3.
McLaughlin K, Scholten R, Parker J, Ferrazzi E, Kingdom J
Br J Clin Pharmacol
. 2017 Dec;
84(4):673-678.
PMID: 29226532
Low molecular weight heparin has been extensively evaluated for the prevention of preeclampsia in high-risk pregnant women; however, the results from these trials have been conflicting. This review discusses the...
4.
McLaughlin K, Wright S, Kingdom J, Parker J
J Obstet Gynaecol Can
. 2017 Jul;
39(11):1008-1014.
PMID: 28733057
Objective: Non-invasive hemodynamic monitoring has the potential to be a valuable clinical tool for the screening and management of hypertensive disorders of pregnancy. The objective of this study was to...
5.
Deter R, Lee W, Kingdom J, Romero R
J Matern Fetal Neonatal Med
. 2017 Mar;
31(7):866-876.
PMID: 28277911
Objectives: To study fetal growth in pregnancies at risk for growth restriction (GR) using, for the first time, the fetal growth pathology score (FGPS1). Methods: A retrospective cohort study of...
6.
McLaughlin K, Baczyk D, Potts A, Hladunewich M, Parker J, Kingdom J
Hypertension
. 2016 Nov;
69(1):180-188.
PMID: 27840330
Low molecular weight heparin (LMWH) has been investigated for the prevention of severe preeclampsia, although the mechanisms of action are unknown. The objective of this study was to investigate the...
7.
Levytska K, Higgins M, Keating S, Melamed N, Walker M, Sebire N, et al.
Am J Perinatol
. 2016 Sep;
34(5):451-457.
PMID: 27649292
Current guidelines for diagnosis and management of early-onset intrauterine growth restriction (IUGR) rely on umbilical artery Doppler (UAD), without including uterine artery Doppler (UtAD). We hypothesized that IUGR cases with...
8.
Deter R, Levytska K, Melamed N, Lee W, Kingdom J
J Matern Fetal Neonatal Med
. 2016 Mar;
29(24):3939-49.
PMID: 26998592
Objective: To compare neonatal growth outcomes determined by birth weight (BW), placental assessment (Plac Assess) and individualized growth assessment (IGA). Methods: This retrospective analysis was carried out in 45 selected...
9.
McLaughlin K, Drewlo S, Parker J, Kingdom J
Hypertension
. 2015 Oct;
66(6):1098-103.
PMID: 26441469
No abstract available.
10.
Amsalem H, Kwan M, Hazan A, Zhang J, Jones R, Whittle W, et al.
J Immunol
. 2014 Aug;
193(6):3070-9.
PMID: 25135830
The maternal leukocytes of the first-trimester decidua play a fundamental role in implantation and early development of the fetus and placenta, yet little is known regarding the second-trimester decidual environment....